Amphastar Pharmaceuticals revenue was $322.36 m in FY, 2019
Amphastar Pharmaceuticals revenue breakdown by business segment: 89.4% from Finished pharmaceutical products and 10.6% from Active Pharmaceutical Ingredients
|FY, 2016||FY, 2015|
|Finished pharmaceutical products||240.22 m||224.94 m|
|Active Pharmaceutical Ingredients||14.94 m||26.58 m|
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.